Ben Ferrari
Career history of Ben Ferrari
Former positions of Ben Ferrari
| Companies | Position | Start | End |
|---|---|---|---|
Imprimatur Capital Ltd.
 Imprimatur Capital Ltd. Investment ManagersFinance Imprimatur Capital Ltd. (Imprimatur Capital) is a venture capital firm founded in 2003 by Ian Watson. The firm is headquartered in London with additional office in Singapore. | Chief Executive Officer | 2011-06-20 | 2011-12-31 |
| Corporate Officer/Principal | 2009-11-24 | 2011-06-20 | |
| University of Surrey | Corporate Officer/Principal | - | - |
| University of St. Andrews | Chief Tech/Sci/R&D Officer | - | - |
| Royal Holloway University of London | Corporate Officer/Principal | - | - |
| Surrey, Inc. | Director/Board Member | - | - |
Evgen Ltd.
 Evgen Ltd. Medical/Nursing ServicesHealth Services Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom. | Director/Board Member | 2009-11-24 | - |
| Independent Dir/Board Member | 2011-06-20 | - |
Statistics
International
| United Kingdom | 6 |
| United States | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
Sectoral
| Consumer Services | 4 |
| Health Services | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Evgen Ltd.
Evgen Ltd. Medical/Nursing ServicesHealth Services Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom. | Health Services |
Imprimatur Capital Ltd.
Imprimatur Capital Ltd. Investment ManagersFinance Imprimatur Capital Ltd. (Imprimatur Capital) is a venture capital firm founded in 2003 by Ian Watson. The firm is headquartered in London with additional office in Singapore. | Finance |
| Surrey, Inc. | Consumer Non-Durables |
- Stock Market
- Insiders
- Ben Ferrari
- Experience
